Green Scientific Labs Holdings Inc. is a leading cannabis and hemp testing laboratory that currently operates one testing lab facility in Florida which provides analytical testing services for state licensed cannabis and hemp growers, product formulators, processors, distributors and retailers. GSL provides industry-leading analysis and testing to the cannabis and hemp industry, under ISO-17025:2017 guidelines, to ensure consumers know in the composition of cannabis and hemp they ingest and to help maximize the quality of its client’s products through research, development and standardization.

Greenrise is a Canadian incorporated publicly traded investment holding company focused on investing in the cannabis industry in Germany.

Grown Rogue International Inc. (CSE: GRIN | OTC: GRUSF) is a craft cannabis company operating in Oregon, Michigan, Minnesota, Maryland, and New Jersey, focused on delighting customers with premium flower and flower-derived products at fair prices. The Company's roots are in Southern Oregon, where it has proven its capabilities in the highly competitive and discerning Oregon market. The Company's passion for quality product and value, combined with a disciplined approach to growth, prioritizes profitability and return on capital without sacrificing quality. The Company's strategy is to pursue capital efficient methods to expand into new markets, bringing craft-quality product at fair prices to more consumers. The Company also continues to make modest investments to improve outdoor craft cultivation capabilities in preparation for eventual interstate commerce. For more information, visit www.grownrogue.com.

Grown Rogue has two classes of equity shares: subordinate voting shares (“SVS”) and multiple voting shares (“MVS”). SVS are publicly traded on the CSE and are entitled to one vote.  MVS are not publicly traded, can convert to SVS at a ratio of 1 MVS to 1,000 SVS, and are entitled to 1,000 votes per MVS.

There are 143,421,865 SVS outstanding and 75,194.941 MVS convertible to 75,194,941 outstanding for a total outstanding SVS of 218,616,806 on an as-converted basis.

Please see Schedule “A” to Grown Rogue’s management information circular dated May 14, 2024 for a further description of the SVS and MVS.

HAVN Life Sciences Inc. is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs and the development of natural health products and innovative therapies to support brain health. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, the company offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle. Learn more at: havnlife.com and follow us on Facebook, Twitter, Instagram and Youtube.